Menu
Clinical Trial
Please contact us for more information or to learn if you are eligible to participate.
The primary goal of this study is to evaluate the safety and tolerability of once-daily, oral administration of 80 or 100 mg resmetirom versus matching placebo.
| Principal Investigator | Gregg Wendorff, MD |
|---|---|
| Co-PI | |
| Sponsor | |
| Type of Trial | Prospective/Interventional |
